An interventional study of Myofascial Release and Classic Massage in Fatigue, sponsored by Luis Gustavo Lizi Jorge. Active, not recruiting at 1 site in Brazil. Open to male participants aged 16 Years to 25 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-04-18.
Sponsored by Luis Gustavo Lizi Jorge · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 57 studies in Fatigue with a site in Brazil — 9 open to participants now, 13 under way, 2 of them phase 3. Fatigue · Brazil.
Among the 57 studies in Fatigue with a site in Brazil, this one is the 50th largest by planned enrollment of the 54 interventional ones that give a count, is one of 3 that started in 2024, is one of 44 with no phase, reaches primary completion later than 10 of the 12 other live ones, and was the 50th registered.
2,234 studies on the registry are indexed under Fatigue; 430 are open to participants now.
Browse Fatigue studies →9 of the 57 studies in Fatigue with a site in Brazil are open now. Recruiting first, the newest first:
Novartis Pharmaceuticals · Sites in Brazil, United States, Australia and 17 more countries
Ages 18+
Federal University of Rio Grande do Sul · Sites in Brazil
Ages 18–45 · Healthy volunteers
Pfizer · Sites in Brazil, United States, Australia and 18 more countries
Ages 18+
Universidade Federal de Sao Carlos · Sites in Brazil
Ages 18–35 · Men only · Healthy volunteers
University of Nove de Julho · Sites in Brazil
Ages 18+ · Healthy volunteers
A study can be open while its sites in Brazil have not opened yet or have stopped. Only those recruiting at a site in Brazil →
Of the 242 Fatigue studies recruiting now, 113 (47%) set no upper age limit and 99 (41%) stop at 75 or younger; 23 take children under 18; 74 take healthy volunteers.
This study: 16 Years to 25 Years · male · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
57 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 6 · Phase 3 3 · Phase 4 2
First in 2005; this study’s year is marked. 3 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 16 is below the median of 54 across 1,762 interventional studies indexed under Fatigue.
Median enrollment 40 across the 54 interventional studies, 50 across the 3 observational. Of the 32 that completed or were terminated, 1 (3%) have results posted.
This tab as a report to print or save as PDF → With an account.
5 of 57 have an industry lead sponsor. The 10 most frequent:
This is the only study on the registry with Luis Gustavo Lizi Jorge as lead sponsor.
Luis Gustavo Lizi Jorge has 1 study filed under Fatigue — fewer than ten, so there is no comparison to draw.
1 of the studies in Fatigue with a site in Brazil that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06933446Luis Gustavo Lizi JorgeEffect of Myofascial Release on Post-Exercise Recovery in Water Polo Athletes | 2026-12-01 |
Add it to your calendar (.ics) → With an account.
Among the 57 studies in Fatigue with a site in Brazil, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Objective: To assess the acute effect of a myofascial release protocol applied to the adductor muscles of the thigh on functional, biomechanical, and physiological variables. Methods: This study is a randomized, double-blind, two-arm crossover clinical trial that will analyze male water polo athletes aged 16 to 25 years recruited from a sports training center in the city of Bauru. Data related to the following parameters will be collected for the physical evaluation: functional performance, through the jump test; biomechanical, through maximum isometric torque of hip adductors, electromyography of the hip and gluteus medius muscles; and physiological, through the analysis of serum markers of muscle damage and inflammation, and heart rate variability. After the initial evaluation, the participants will be randomly divided into two groups: intervention group and sham group. Then, all participants will perform a game simulation. After the game, the participants will receive the intervention designated for each group. For the intervention group, a manual therapy protocol will be applied, based on myofascial release in the thigh region that presents trigger points. For the Sham group, a manual technique, called classic massage, will be applied, with superficial pressure, used to reach only subcutaneous tissues, without acting on muscles and fascia. This protocol will be repeated at four different times, always after the games. After a washout week, the participants will change groups and the data collection protocol will be applied again.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Other: Classic Massage
Other: Myofascial Release
A myofascial release protocol, applied to the thigh muscles in post-effort recovery in water polo athletes.
Massagem clássica, com pressão superficial, utilizada para atingir apenas tecidos subcutâneos, sem que haja ação sobre músculos e fáscias
Maximum Vertical Jump Test
Time frame: From enrollment to the end of treatment at 2 weeks
Maximum Voluntary Isometric Torque of the Hip Adductors
Time frame: From enrollment to the end of treatment at 2 weeks
Electromyography of Adductors, Gluteus Medius and Transversus Abdominis
Time frame: From enrollment to the end of treatment at 2 weeks
Collection of Serum Markers
The markers: creatine kinase (CK; Units of Measure= U/L), lactate dehydrogenase (LDH; Units of Measure= UI/L), myoglobin (Myo; Units of Measure= ng/mL), erythrocyte sedimentation rate (ESR; Units of Measure= mm/h), tumor necrosis factor alpha (TNFA; Units of Measure= Å) will be considered for analysis of muscle damage markers and will be determined through specific kits and following the manufacturer's instructions.
Time frame: From enrollment to the end of treatment at 2 weeks
Heart Rate Variability
Heart rate variability (HRV) will be collected, at rest, through a non-invasive method used to measure cardiac autonomic control, to assess the autonomic nervous system (ANS), and the RR interval will be recorded by a portable heart rate monitor.
Time frame: From enrollment to the end of treatment at 2 weeks
Effort Control Variables: Subjective Perception of Exertion and Lactate Threshold
To estimate the intensity of the exercise, the method proposed by Foster (1998) will be used, which suggests multiplying the subjective perception of exertion (RPE) of the session by the total duration of the training session (sRPE), with the results expressed in arbitrary units (u.a.). To quantify performance during the game, lactate will be collected at the end of each quarter of the game, through blood collections from the earlobe (25 μL) to analyze the peak lactate concentration (\[La-\]peak) of the effort.
Time frame: From enrollment to the end of treatment at 2 weeks
Plan to share: No
No publications or documents are linked to this record.
Started Feb 2024 (actual). Primary completion is estimated for Dec 2026, 34 months after the start.
Of 937 non-industry interventional studies with no phase under Fatigue, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 27. This study's planned 34 months is above that.
Counting every sponsor, half of 990 studies reached it within 12 months; a quarter within 5 and three quarters within 27.
How these figures are worked out, and which studies are left out of them.
This study is active, not recruiting, as verified in Apr 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.